Clinical Trials Browser

Phase 1/2 × OTHER × Receptor Protein-Tyrosine Kinases × Clear all

NCT00677287 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Phase 1/2 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00677326 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms

NCT00677612 2009-12-29

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Phase 1/2 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00681252 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00681421 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Phase 1/2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT00681577 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00683358 2009-05-07

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Phase 1/2 Unknown

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00673777 2008-05-14

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung